Lucid Diagnostics Stock Forecast - Total Risk Alpha

LUCD Stock  USD 0.89  0.02  2.20%   
Lucid Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Lucid Diagnostics stock prices and determine the direction of Lucid Diagnostics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Lucid Diagnostics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Lucid Diagnostics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Lucid Diagnostics' systematic risk associated with finding meaningful patterns of Lucid Diagnostics fundamentals over time.
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.
  
At present, Lucid Diagnostics' Receivables Turnover is projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 0.97, whereas Inventory Turnover is forecasted to decline to 17.13. . As of June 2, 2024, Common Stock Shares Outstanding is expected to decline to about 41.1 M. The current year's Net Loss is expected to grow to about (48 M).
Lucid Diagnostics has current Total Risk Alpha of 0.
Most investors in Lucid Diagnostics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Lucid Diagnostics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Lucid Diagnostics' price structures and extracts relationships that further increase the generated results' accuracy.
Check Lucid Diagnostics VolatilityBacktest Lucid DiagnosticsInformation Ratio  

Lucid Diagnostics Trading Date Momentum

On June 02 2024 Lucid Diagnostics was traded for  0.89  at the closing time. The top price for the day was 0.93  and the lowest listed price was  0.89 . There was no trading activity during the period 0.0. Lack of trading volume on June 2, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.12% .
Compare Lucid Diagnostics to competition

Other Forecasting Options for Lucid Diagnostics

For every potential investor in Lucid, whether a beginner or expert, Lucid Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lucid Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lucid. Basic forecasting techniques help filter out the noise by identifying Lucid Diagnostics' price trends.

View Lucid Diagnostics Related Equities

 Risk & Return  Correlation

Lucid Diagnostics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lucid Diagnostics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lucid Diagnostics' current price.

Lucid Diagnostics Market Strength Events

Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns.

Lucid Diagnostics Risk Indicators

The analysis of Lucid Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lucid Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lucid stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Lucid Diagnostics to cross-verify your projections.
For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.
Note that the Lucid Diagnostics information on this page should be used as a complementary analysis to other Lucid Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Lucid Stock analysis

When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Lucid Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.26)
Revenue Per Share
0.07
Quarterly Revenue Growth
1.244
Return On Assets
(0.69)
Return On Equity
(2.56)
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.